Memorializing Governor Kathy Hochul to proclaim October 2025, as AVM Awareness Month in the State of New York
Summary
This resolution memorializes Governor Kathy Hochul to proclaim October 2025 as AVM Awareness Month in New York State, in conjunction with National AVM Awareness Month. It is a ceremonial measure that does not create a regulatory program or mandate; instead, it expresses the Legislature’s support for public awareness of brain arteriovenous malformations (AVMs) and related neurological conditions.
The resolution explains that AVMs are abnormal artery-vein connections, often in the brain or spine, that can be life-threatening if undetected or if they rupture. It highlights that AVMs are rare, may be difficult to detect, and can lead to hemorrhage, stroke, or brain damage, and it cites the Joe Niekro Foundation and other support groups as partners in awareness and research efforts.
Impact
The bill would not amend the New York Consolidated Laws or impose duties on state agencies, local governments, insurers, or healthcare providers. Its practical effect is limited to a formal legislative request that the Governor issue a proclamation designating October 2025 as AVM Awareness Month, which may help promote public education, fundraising, and outreach around AVM diagnosis, treatment, and neurological research.
Sentiment
The available context suggests broad, supportive sentiment. The resolution is framed in customary celebratory terms, emphasizing the importance of awareness for a serious but rare medical condition and the value of supporting affected patients and research efforts. There are no recorded committee transcripts or votes indicating opposition, amendment, or controversy.
Contention
No specific points of contention are evident in the provided record. Because the measure is a nonbinding memorializing resolution, there is little apparent policy dispute; any discussion would likely center on the usefulness of awareness proclamations generally, or on whether state attention should be directed toward this rare condition versus other public health priorities. No opposing viewpoints are documented in the materials provided.